These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 3517417)

  • 21. Significance of persistent Auer rods and cytogenetic abnormality after first cycle of therapy for acute promyelocytic leukaemia.
    Dalal BI; Bruyere H; Barnett MJ
    Br J Haematol; 2007 Jun; 137(5):385. PubMed ID: 17374141
    [No Abstract]   [Full Text] [Related]  

  • 22. [Induction of remission by sequential treatment with cytosine arabinoside (araC/high dose) and L-asparaginase].
    Martín-Aragonés G; Sanz MA; Martínez JA; Rafecas FJ; Gomis F; Lorenzo I; Sanz G; Marty ML
    Sangre (Barc); 1985; 30(1):15-21. PubMed ID: 3859023
    [No Abstract]   [Full Text] [Related]  

  • 23. Effect of antimetabolites and thymidine blockage on the induction of differentiation of HL-60 cells by retinoic acid or 1 alpha,25-dihydroxyvitamin D3.
    Ishikura H; Okazaki T; Mochizuki T; Izumi Y; Tashima M; Sawada H; Uchino H
    Exp Hematol; 1985 Nov; 13(10):981-8. PubMed ID: 3932088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fundamentals of chemo-differentiation therapy of myeloid leukemia.
    Hozumi M
    Anticancer Res; 1994; 14(3A):1177-92. PubMed ID: 8074470
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth response of residual leukemia after initial drug therapy.
    Karp JE; Burke PJ
    Cancer Res; 1986 Aug; 46(8):4205-7. PubMed ID: 3731087
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stimulation by interferon of induction of differentiation of mouse myeloid leukemic cells.
    Tomida M; Yamamoto Y; Hozumi M
    Cancer Res; 1980 Aug; 40(8 Pt 1):2919-24. PubMed ID: 6155998
    [No Abstract]   [Full Text] [Related]  

  • 27. Terminal differentiation of the human promyelocytic leukemia cell line, HL-60, in the absence of cell proliferation.
    Ferrero D; Tarella C; Gallo E; Ruscetti FW; Breitman TR
    Cancer Res; 1982 Nov; 42(11):4421-6. PubMed ID: 6957259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Protection of cells by nucleoside transport inhibitor combined with nebularine and the therapeutic effect on transplantable mouse tumors].
    Fu NW
    Zhonghua Zhong Liu Za Zhi; 1985 Mar; 7(2):94-8. PubMed ID: 3874052
    [No Abstract]   [Full Text] [Related]  

  • 29. Sequential high-dose ara-C and asparaginase in the therapy of previously treated and untreated patients with acute leukemia.
    Capizzi RL; Powell BL; Cooper MR; Stuart JJ; Muss HB; Richards F; Jackson DV; White DR; Spurr CL; Zekan PJ
    Semin Oncol; 1985 Jun; 12(2 Suppl 3):105-13. PubMed ID: 3892697
    [No Abstract]   [Full Text] [Related]  

  • 30. [Cellular synchronization and "recruitment" in antineoplastic chemotherapy].
    Lingetti M; Belli M; Guerriero C; Rumiano C; Ciarimboli M; Policicchio D
    Clin Ter; 1980 Apr; 93(2):203-11. PubMed ID: 7449338
    [No Abstract]   [Full Text] [Related]  

  • 31. Effects of retinoids on induction of differentiation of cultured mouse myeloid leukemia cells.
    Takenaga K; Hozumi M; Sakagami Y
    Cancer Res; 1980 Mar; 40(3):914-9. PubMed ID: 6937243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Macromolecular and cell cycle effects of different classes of agents inducing the maturation of human myeloblastic leukemia (ML-1) cells.
    Craig RW; Frankfurt OS; Sakagami H; Takeda K; Bloch A
    Cancer Res; 1984 Jun; 44(6):2421-9. PubMed ID: 6586286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Teniposide: a review of 12 years of experience.
    O'Dwyer PJ; Alonso MT; Leyland-Jones B; Marsoni S
    Cancer Treat Rep; 1984 Dec; 68(12):1455-66. PubMed ID: 6391663
    [No Abstract]   [Full Text] [Related]  

  • 34. Retinoic acids in the treatment of acute promyelocytic leukemia.
    Castaigne S; Chomienne C; Daniel MT; Berger R; Miclea JM; Ballerini P; Degos L
    Nouv Rev Fr Hematol (1978); 1990; 32(1):36-8. PubMed ID: 2190178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carnosic acid inhibits proliferation and augments differentiation of human leukemic cells induced by 1,25-dihydroxyvitamin D3 and retinoic acid.
    Steiner M; Priel I; Giat J; Levy J; Sharoni Y; Danilenko M
    Nutr Cancer; 2001; 41(1-2):135-44. PubMed ID: 12094616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Microbial iron chelator-induced cell cycle synchronization in L1210 cells: potential in combination chemotherapy.
    Bergeron RJ; Ingeno MJ
    Cancer Res; 1987 Nov; 47(22):6010-6. PubMed ID: 3664504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The therapy of myelodysplastic syndromes].
    Aul C; Heyll A
    Dtsch Med Wochenschr; 1990 Nov; 115(48):1842-50. PubMed ID: 2245768
    [No Abstract]   [Full Text] [Related]  

  • 38. [Differentiation--inducing therapy].
    Kizaki M
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():207-10. PubMed ID: 23133954
    [No Abstract]   [Full Text] [Related]  

  • 39. Molecular targets and the treatment of myeloid leukemia.
    Ikeda A; Shankar DB; Watanabe M; Tamanoi F; Moore TB; Sakamoto KM
    Mol Genet Metab; 2006 Jul; 88(3):216-24. PubMed ID: 16678459
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Differentiation induction of myeloid leukemia cells by glucocorticoid--the differentiation induction effect in vitro and in vivo].
    Nakamaki T; Sakashita A; Sano M; Hino K; Suzuki K; Tomoyasu S; Tsuruoka N
    Rinsho Ketsueki; 1989 Feb; 30(2):149-57. PubMed ID: 2746870
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.